The FDA accepts Eli Lilly's NDA for empagliflozin plus immediate-release metformin hydrochloride for the treatment of adults with type 2 diabetes (T2D). The product is part of the Lilly/Boehringer Ingelheim Diabetes alliance portfolio. ... Seeking Alpha, 2 days ago
FDA Accepts Lilly's NDA Filing For Empagliflozin/metformin Combination - RTTNews.com, 2 days ago
Boehringer and Lilly receive FDA acceptance for NDA of type 2 diabetes drug - Individual.com, 5 hours ago
Keeps mum on Sena presence in NDA In response to Shiv Sena's Mission 150 Plus target, the Bharatiya Janata Party (BJP) yesterday unveiled its own Mission 145 Plus in its Assembly election campaign. However, BJP's state in-charge, Rajiv Pratap ...Afternoon Despatch & Courier, 3 weeks ago Decoding NCP's Maha Gambit Meri News, 2 days ago Sena-BJP : Rudy, Tawde want 'Mahayuti' to continue Afternoon Despatch & Courier, 1 month ago
In Dhar, at a garba venue. With six MPs, the Lok Janshakti Party may not count for much in the 330-plus ruling NDA. But ABDUL KHALIQ, secretary general of LJP, is the first ally to speak out against the unfettered hate being spewed against Muslims ...Indian Express, 3 weeks ago
The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment ...PharmaceuticalProcessing, 2 days ago USFDA accepts filing of NDA for empagliflozin/metformin FDC PharmaBiz, 1 day ago U.S. FDA Accepts Filing Of NDA for Empagliflozin/Metformin Fixed-Dose Combination Drugs.com, 1 day ago
NEW DELHI: CPI(M) today hit out at the BJP- led government for deregulating diesel pricing, saying this amounted to "abdication of its responsibility" of regulating prices of a crucial item which directly impacts general inflation. "This is ...Economic Times, 3 days ago CPI(M) Hits Out at NDA Govt Over Diesel Price Deregulation Outlook India, 3 days ago
More from: , Financial Express...and 1 other sources
The benchmark indices remain upbeat due to the surge in the shares of financials, pharma and oil and gas companies . NDA's electoral victory plus the energy reforms are primarily responsible for the rally though the global cues are also strong with ...Business Standard India, 3 days ago
ashtriya Swayamsevak Sangh (RSS) has said that the NDA Government has till 2019 to act on the issue of constructing a grand Ram Janambhoomi Temple in Ayodhya, Uttar Pradesh. The BJP, in its election manifesto, had promised to build a temple on the ...Business Standard India, 5 days ago
More from: , Yahoo! India...and 2 other sources
The Sahara Group is believed to be working on a $1-billion-plus debt refinancing deal with two American hedge funds for raising funds to secure release of its jailed chief Subrata Roy, according to a media report. The two funds would become ...Business Today India, 1 week ago
H. Lundbeck A/S, a manufacturer of pharmaceuticals for the treatment of brain disorders, and Otsuka Pharmaceutical Co., Ltd. have announced that the new drug application, or NDA, for brexpiprazole for monotherapy in adult patients with schizophrenia ...Individual.com, 3 weeks ago U.S. FDA Accepts Otsuka and Lundbeck's Filing for Review of Brexpiprazole for the Treatment of Schizophrenia and as Adjunctive Therapy for the Treatment of Major Depression Morningstar.com, 4 weeks ago U.S. FDA Accepts sNDA For Antiepileptic Agent Fycompa as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures FirstWord Pharma, 1 day ago H. Lundbeck A/S - De amerikanske sundhedsmyndigheder (FDA) har accepteret Otsuka og Lundbecks registreringsansøgning for brexpiprazol til behandling af skizofreni og til kombinationsbehandling af svær depression Scottrade, 4 weeks ago
Gilead soumet une demande de nouveau médicament (NDA) auprès de lAgence japonaise des produits pharmaceutiques et dispositifs médicaux pour la combinaison à dose fixe de ledipasvir/sofosbuvir dans le traitement de lhépatiteC...
FOSTER CITY, Californie--( BUSINESS WIRE )-- Gilead soumet une demande de nouveau médicament (NDA) auprès de lAgence japonaise des produits pharmaceutiques et dispositifs médicaux pour la combinaison à dose fixe de ...Business Wire, 4 weeks ago
on your WebpageAdd Widget >Get your members hooked!